Home /

How Ozempic and Wegovy are reshaping Denmark's economy

By Eshe Nelson
New York Times·
7 mins to read

After 100 years of relatively quiet existence as a maker of diabetes drugs, Danish firm Novo Nordisk has suddenly grown so big that the company is drastically reshaping the Danish economy.

The reason: Ozempic and Wegovy, two weight-loss drugs made by Novo Nordisk that have been proclaimed as revolutionary in the field of obesity.

The company’s booming success explains almost all of Denmark’s recent economic growth, and the surge in overseas sales in the drugs is prompting the Danish central

Save